Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2Phase 4 2Phase 3 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Breast Neoplasms 18Neoplasms 16Prostatic Neoplasms 12Neoplasm Metastasis 10Pain 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Polycystic Ovary Syndrome 7Leiomyoma 6Anemia 5Skin Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia 4Carcinoma, Renal Cell 4Recurrence 3Melanoma 3Liver Neoplasms 3Kidney Neoplasms 3Keratosis, Actinic 3Insulin Resistance 3Carcinoma, Hepatocellular 3Cancer Pain 3Brain Neoplasms 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Stomach Neoplasms 2

Interventions

Desvenlafaxine Succinate 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Hot Flashes × Clear all
NCT03796195 2023-01-25

(SGB) in Men Treated for Prostate Cancer Improve Hot Flashes

Northwestern University

Phase 4 Terminated
1 enrolled 9 charts
Genitourinary

Prostatic Neoplasms, Hot Flashes

NCT02819921 2019-09-20

Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen

Seoul National University Hospital

Phase 4 Terminated
59 enrolled
Breast

Breast Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡